메뉴 건너뛰기
Inflammatory Bowel Diseases
Volumn 11, Issue 6, 2005, Pages 616-617
Debate: Should mesalamine be used in Crohn's disease? Comments and conclusions
Author keywords

[No Author keywords available]
Indexed keywords

MESALAZINE;
EID: 20444468427     PISSN: 10780998     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.MIB.0000160744.32396.02     Document Type: Review
Times cited : (7)
References (6)
  • 1
    • 0027528294 scopus 로고
    • Oral mesalamine (Pentasa) as maintenance treatment in Crohn's disease: A multicenter placebo-controlled study
    • Gendre JP, Mary JY, Florent C, et al. Oral mesalamine (Pentasa) as maintenance treatment in Crohn's disease: a multicenter placebo-controlled study. Gastroenterology. 1993;104:435-439.
    • (1993) Gastroenterology , vol.104 , pp. 435-439
    • Gendre, J.P.1    Mary, J.Y.2    Florent, C.3
  • 2
    • 0027218241 scopus 로고
    • Mesalamine capsules for the treatment of active Crohn's disease: Results of a 16-week trial
    • Pentasa Crohn's Disease Study Group
    • Singleton JW, Hanauer SB, et al. Mesalamine capsules for the treatment of active Crohn's disease: results of a 16-week trial. Pentasa Crohn's Disease Study Group. Gastroenterology. 1993;104:1293-1301.
    • (1993) Gastroenterology , vol.104 , pp. 1293-1301
    • Singleton, J.W.1    Hanauer, S.B.2
  • 3
    • 0024429141 scopus 로고
    • A placebo-controlled, double-blind, randomized trial of cyclosporine therapy in active chronic Crohn's disease
    • Brynskov J, Freund L, Rasmussen SN, et al. A placebo-controlled, double-blind, randomized trial of cyclosporine therapy in active chronic Crohn's disease. N Engl J Med. 1989;321:845-850.
    • (1989) N Engl J Med , vol.321 , pp. 845-850
    • Brynskov, J.1    Freund, L.2    Rasmussen, S.N.3
  • 4
    • 15944427956 scopus 로고    scopus 로고
    • The peroxisome proliferators-activated receptor gamma (PPARγ) mediates the anti-inflammatory effect of 5-aminosalicylic acid (5-ASA) in the intestine
    • Rousseaux C, Lefebvre B, Dubuquoy L, et al. The peroxisome proliferators-activated receptor gamma (PPARγ) mediates the anti-inflammatory effect of 5-aminosalicylic acid (5-ASA) in the intestine. Gastroenterology. 2004; 126(Suppl 2):A-129.
    • (2004) Gastroenterology , vol.126 , Issue.SUPPL. 2
    • Rousseaux, C.1    Lefebvre, B.2    Dubuquoy, L.3
  • 5
    • 0842286558 scopus 로고    scopus 로고
    • Initial experience with wireless capsule enteroscopy in the diagnosis and management of inflammatory bowel disease
    • Mow WS, Lo SK, Targan SR, et al. Initial experience with wireless capsule enteroscopy in the diagnosis and management of inflammatory bowel disease. Clin Gastroenterol Hepatol. 2004;2:31-40.
    • (2004) Clin Gastroenterol Hepatol , vol.2 , pp. 31-40
    • Mow, W.S.1    Lo, S.K.2    Targan, S.R.3
  • 6
    • 0033937522 scopus 로고    scopus 로고
    • Interaction of 6-mercaptopurine and azathioprine with 5-aminosalicylic acid agents
    • Present DH. Interaction of 6-mercaptopurine and azathioprine with 5-aminosalicylic acid agents (letter). Gastroenterology. 2000;119:276.
    • (2000) Gastroenterology , vol.119 , pp. 276
    • Present, D.H.1

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.